About
Cagent Vascular is a medical device company dedicated to enhancing the treatment of cardiovascular disease, particularly peripheral artery disease (PAD). The company specializes in developing innovative angioplasty balloons using its proprietary Serration Technology. This technology aims to optimize therapy outcomes and reduce complications associated with traditional angioplasty procedures. The flagship product, the Serranator, is a next-generation angioplasty balloon designed to achieve predictable lumen gain. Its unique serrated edge technology allows for more uniform expansion of blood vessels, addressing common complications like vessel recoil and dissection. Clinical data supports the effectiveness of this technology, showcasing improved treatment outcomes. Cagent Vascular focuses on advancing minimally invasive cardiovascular treatments and is actively engaged in clinical studies and strategic partnerships to broaden its product distribution internationally. The company targets healthcare providers and institutions specializing in cardiovascular care, providing them with enhanced tools for treating PAD and other cardiovascular conditions. Cagent Vascular also emphasizes education and awareness, sharing clinical data and updates about its technology and impact on vascular care.
Technologies
Keywords
Company Information
-
Employees 77
-
Founded 2014
-
Annual Revenue $9800000
-
Total Funding $73118488
Location
150 Strafford Avenue, Wayne, Pennsylvania, United States, 19087
